SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005646
Filing Date
2014-11-13
Accepted
2014-11-13 16:12:03
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20140930.htm 10-Q 814245
2 EX-31.1 evok-ex311_201409306.htm EX-31.1 9861
3 EX-31.2 evok-ex312_201409307.htm EX-31.2 9939
4 EX-32.1 evok-ex321_201409308.htm EX-32.1 4524
5 EX-32.2 evok-ex322_201409309.htm EX-32.2 4636
  Complete submission text file 0001564590-14-005646.txt   2991296

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20140930.xml EX-101.INS 388224
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20140930.xsd EX-101.SCH 20224
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20140930_cal.xml EX-101.CAL 19809
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20140930_def.xml EX-101.DEF 55052
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20140930_lab.xml EX-101.LAB 156439
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20140930_pre.xml EX-101.PRE 117254
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 141218575
SIC: 2834 Pharmaceutical Preparations